Literature DB >> 24637286

[Late effects, social adjustment, and quality of life in adolescent survivors of childhood leukemia].

Sung Sil Hong1, Ho Ran Park2, Kwang Sung Kim3, Sun Hee Choi3.   

Abstract

PURPOSE: This study was conducted to examine the late effects, social adjustment, and quality of life in adolescents who had been completely treated for childhood leukemia and their parents.
METHODS: Participants consisted of 41 pairs of adolescent survivors (13-18 years) and their parents. Parents checked for their child's physical late effects. The Korean Version of Post-Traumatic Symptoms for psychological late effects, social functioning questionnaire for social adjustment and the PedsQL 4.0 Generic Core Scales for quality of life were completed by adolescents and parents. Data were analyzed using SPSS.
RESULTS: Twenty out of 41 adolescents had one or more physical late effects. Adolescents showed more serious psychological late effect than parents. Five children and seven parents had above cut-off scores and they were considered the high risk group for posttraumatic symptoms. Parent-reported scores were significantly higher than child-reported scores in terms of social adjustment and emotional functioning of quality of life. Low school functioning in adolescents was associated with physical late effects.
CONCLUSION: The results indicate that long-term and systematic management for childhood leukemia survivors affect positive social adjustment and can further improve quality of life.

Entities:  

Keywords:  Late effect; Leukemia; Quality of life; Social adjustment; Survivors

Mesh:

Year:  2014        PMID: 24637286     DOI: 10.4040/jkan.2014.44.1.55

Source DB:  PubMed          Journal:  J Korean Acad Nurs        ISSN: 2005-3673            Impact factor:   0.984


  1 in total

1.  Impact of Ego-resilience and Family Function on Quality of Life in Childhood Leukemia Survivors.

Authors:  Ok-Hee Cho; Yang-Sook Yoo; Kyung-Hye Hwang
Journal:  Iran J Public Health       Date:  2016-11       Impact factor: 1.429

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.